Invention Grant
US09028840B2 Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens
有权
用于制备含有对EBV结构抗原特异性的CD4 + T细胞的制剂的离体方法
- Patent Title: Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens
- Patent Title (中): 用于制备含有对EBV结构抗原特异性的CD4 + T细胞的制剂的离体方法
-
Application No.: US12744474Application Date: 2008-11-27
-
Publication No.: US09028840B2Publication Date: 2015-05-12
- Inventor: Dinesh Adhikary , Uta Behrends , Josef Mautner , Henri-Jacques Delecluse , Regina Feederle
- Applicant: Dinesh Adhikary , Uta Behrends , Josef Mautner , Henri-Jacques Delecluse , Regina Feederle
- Applicant Address: DE Neuherberg DE Heidelberg
- Assignee: Helmholtz Zentrum Munchen Deutsches Forschungzentrum fur Gesundheit und Umwelt (GmbH),Deutsches Krebsforschungzentrum (DKFZ)
- Current Assignee: Helmholtz Zentrum Munchen Deutsches Forschungzentrum fur Gesundheit und Umwelt (GmbH),Deutsches Krebsforschungzentrum (DKFZ)
- Current Assignee Address: DE Neuherberg DE Heidelberg
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: EP07121683 20071127
- International Application: PCT/EP2008/066347 WO 20081127
- International Announcement: WO2009/068615 WO 20090604
- Main IPC: A61K39/245
- IPC: A61K39/245 ; C12N5/0783 ; A61K39/00
Abstract:
The present invention discloses an ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens for use in the prophylaxis and treatment of patients with a reduced T cell activity in order to prevent or treat growth of EBV infected B cells.
Public/Granted literature
- US20110059133A1 EX VIVO METHOD FOR PRODUCING A PREPARATION CONTAINING CD4+ T CELLS SPECIFIC FOR EBV STRUCTURAL ANTIGENS Public/Granted day:2011-03-10
Information query
